Position in AVXL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,306,741
-$162,874 QoQ
Shares Held
890,634
+10.7% QoQ
Ownership
0.961%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 179 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Derivatives in AVXL
reported options exposure · as of Sep 30, 2024CallValue
$0
CallShares
0
PutValue
$894,032
PutShares
157,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. AVXL ranks #225 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in AVXL
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,306,741 | 890,634 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,469,615 | 804,435 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,107,765 | 872,968 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $2,700,161 | 303,389 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,708,651 | 293,780 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,532,033 | 411,659 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $5,783,930 | 538,541 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $894,032 | 157,400 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $3,760,738 | 662,102 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,929,227 | 457,163 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,719,138 | 534,212 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,481,794 | 266,573 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $1,447,661 | 221,017 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $2,603,225 | 320,200 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $2,163,925 | 252,500 | Put | Defined | 2024-05-14 | |
| 2023-03-31 | $5,757,428 | 671,812 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $6,508,899 | 702,905 | Shares | Defined | 2023-02-13 | |
| 2022-12-31 | $2,236,290 | 241,500 | Put | Defined | 2023-02-13 | |
| 2022-09-30 | $3,192,109 | 309,313 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,582,177 | 357,860 | Shares | Defined | 2022-08-18 | |
| 2022-03-31 | $5,401,184 | 438,764 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $6,597,262 | 380,465 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $1,932,747 | 107,674 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $2,060,074 | 90,117 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,031,286 | 135,872 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $185,841 | 34,415 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $109,645 | 24,098 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $105,716 | 21,487 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $130,334 | 41,376 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||